ArticleOncotarget2015

Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo.

Han-Li Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.